FDA Approves Antibiotic Combination for Complicated UTIs
Cefepime-enmetazobactam beat piperacillin-tazobactam in phase III study
Source: medpagetoday.com
Keith Kaye News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Keith Kaye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Keith Kaye Today - Breaking & Trending Today
Sulbactam-Durlobactam FDA-Approved for Bacterial Pneumonia
Trade name Xacduro is an antibiotic meant to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by Acinetobacter baumannii.
Source: infectioncontroltoday.com
New antibiotic may soon treat scary 'ABC' pneumonia
The combo antibiotic sulbactam-durlobactam fights dangerous pneumonia at least as well as the best currently approved treatment, a trial shows.
Source: futurity.org
Could FDA recommend new antibiotic for often-fatal pneumonia?
A new combination antibiotic for hospital-acquired pneumonia offers advantages in dosing and tolerability, a Phase III trial has shown.
Source: europeanpharmaceuticalreview.com
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet Infectious Diseases
Sulbactam-durlobactam is the first pathogen-targeted therapy under investigation for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by... | May 11, 2023
Source: marketscreener.com